September 2017 FDA Recall Drug by Teva Pharmaceuticals Usa
D-1178-2017 - Labeling

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on September 5, 2017 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1178-2017

Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.
Initiated
09-05-2017
Reported
10-04-2017
Quantity
3,275 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA
Nationwide in the USA
Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.

Batch or Lot Expiration Information

Lot# : 1082710A, Exp 07/18